Publications by authors named "Abu Fanne Rami"

Polyvascular disease, is a prevalent comorbidity among patients with acute heart failure (AHF). Previous research has shown that polyvascular disease is a poor prognostic factor in patients with heart failure. However, data on the relationship between the extent of vascular disease involvement and outcomes in AHF patients are limited.

View Article and Find Full Text PDF
Article Synopsis
  • Cardiogenic shock (CS) is a critical concern for patients with acute myocardial infarction (AMI), particularly those with multiple vascular diseases, leading to higher mortality rates.
  • The study analyzed data from over 136,000 patients with AMI and CS, revealing that as the number of diseased vascular beds increases, the likelihood of receiving invasive procedures like PCI and CABG decreases, which also correlates with worse health outcomes.
  • The findings emphasize the need for early detection and aggressive treatment of polyvascular disease to improve management and outcomes for AMI patients experiencing cardiogenic shock.
View Article and Find Full Text PDF
Article Synopsis
  • During the early months of the COVID-19 pandemic, the U.S. saw a 24.8% increase in atrial fibrillation (AF)-related mortality, particularly affecting young individuals and minorities.
  • The study analyzed over 1.2 million AF-related death cases across three time periods: before, during, and after the pandemic peak, using CDC data.
  • Results indicate a need for targeted healthcare policies to address AF and its associated disparities among various demographics, especially during future health crises.
View Article and Find Full Text PDF
Article Synopsis
  • Diabetes mellitus (DM) worsens the outcomes for patients suffering from acute myocardial infarction (AMI) complicated by cardiogenic shock (CS) and polyvascular disease, increasing their risk of serious health issues.
  • A study analyzing over 39,000 patients found that those with DM were younger and more likely to be female, and they faced a 17% higher risk of mortality as well as an increased chance of adverse cardiovascular events compared to those without DM.
  • The results highlight the need for specialized care and interventions for patients with DM and AMI complicated by CS, as these individuals experience longer hospital stays and higher costs due to their increased health risks.
View Article and Find Full Text PDF
Article Synopsis
  • Inflammation is key in the development of atherosclerosis, and alpha-defensin, a neutrophilic peptide, may be a potential risk factor for cardiovascular events.
  • A study involving 174 patients showed that those with higher baseline alpha-defensin levels had a 20% increased level among patients who passed away, suggesting a strong link between higher levels and mortality risk.
  • The findings indicate that plasma alpha-defensin can independently predict mortality and need for repeat procedures in stable coronary artery disease patients, highlighting its potential for future cardiovascular risk assessments.
View Article and Find Full Text PDF

While the vast majority of Alzheimer's disease (AD) is non-familial, the animal models of AD that are commonly used for studying disease pathogenesis and development of therapy are mostly of a familial form. We aimed to generate a model reminiscent of the etiologies related to the common late-onset Alzheimer's disease (LOAD) sporadic disease that will recapitulate AD/dementia features. Naïve female mice underwent ovariectomy (OVX) to accelerate aging/menopause and were fed a high fat-sugar-salt diet to expose them to factors associated with increased risk of development of dementia/AD.

View Article and Find Full Text PDF
Article Synopsis
  • A significant number of patients undergoing percutaneous coronary intervention (PCI) have few or no standard modifiable cardiovascular risk factors (SMuRFs), such as hypertension, diabetes, hypercholesterolemia, and smoking.
  • The study analyzed patients based on how many SMuRFs they had and found that as the number of SMuRFs increased, the risk of target lesion failure (TLF) also rose significantly.
  • Patients without SMuRFs had better outcomes, but there's a need for further research to improve treatment strategies for the majority who do have risk factors.
View Article and Find Full Text PDF

Tramadol is primarily metabolized by the highly polymorphic enzyme, leading to a large spectrum of adverse events and clinical response. Ample evidence pointed a reduced CYPD26 activity score in individuals harboring the genotype, nevertheless, there is scarce studies on the impact of *10/*10 genetic polymorphism on long-term tramadol's adverse effects. To test the correlation between *10/*10 expression and the risk for tramadol-associated adverse effects.

View Article and Find Full Text PDF
Article Synopsis
  • A large number of patients over 50 undergoing coronary angiography often have normal or non-obstructive coronary artery disease, leading to a study on their long-term outcomes and re-catheterization rates.
  • Out of 1939 NOCAD patients identified, 90% did not require repeat angiography while 10% did; among those who had repeat procedures, a small percentage resulted in successful angioplasty.
  • Key risk factors like male gender, obesity, hypertension, diabetes, and smoking were more prevalent in patients needing intervention, and many were not regularly prescribed statins or aspirin for treatment.
View Article and Find Full Text PDF
Article Synopsis
  • - The study evaluates the outcomes of patients with multivessel disease (MVD) who received surgical revascularization after a remote consultation, particularly focusing on the rate of anatomical complete revascularization (ACR) and its impact on patient mortality.
  • - Out of 314 included patients, those who underwent ACR showed significantly higher 4-year mortality rates compared to those who had not, indicating that ACR may be linked to better survival outcomes.
  • - The research suggests that performing partial revascularization without a structured heart team may lead to higher than expected mortality and other adverse events, highlighting the need for better collaborative treatment approaches in centers lacking on-site surgical services.
View Article and Find Full Text PDF

Background-Various antidepressant agents are metabolized by the CYP2C19 enzyme, including Citalopram and Escitalopram. Variation in CYP2C19 expression might give rise to different plasma concentrations of the active metabolites, potentially affecting both drugs' efficacy and tolerability. Aim-The aim of this study was to evaluate differences in the Escitalopram and Citalopram efficacy and tolerability between different CYP2C19 genotype-based metabolizing categories in outpatients suffering from major depressive disorder (MDD).

View Article and Find Full Text PDF

Introduction: High-sensitivity cardiac troponin T (hs-cTnT) is not used routinely as a diagnostic biomarker in newborns. The high precision of hs-cTnT assays increases the ability to determine small differences in cTnT over time and to detect troponin T elevation; thus, we believe that hs-cTnT assays might improve clinical care. We explored the plausible association between hs-cTnT levels (ng/L) in healthy newborns and prolonged second stage of labor, neonatal, and maternal factors.

View Article and Find Full Text PDF

It is prudent to develop biomarkers that enhance the differentiation between viral and bacterial infection in order to support expeditious and judicious antimicrobial implementation in emergency department admissions. Human neutrophilic peptides 1-3 (HNP1-3) are the major neutrophilic peptides with potent antimicrobial activity. We tested the performance of the plasma HNP1-3 test in a prospective observational cohort of children admitted to the emergency department for fever.

View Article and Find Full Text PDF

Risk models to estimate percutaneous coronary intervention (PCI) mortality have limited value in complex high-risk patients. However, it was improved by a recently developed bedside model to predict in-hospital mortality using data from the American College of Cardiology CathPCI Registry that included 706,263 patients. The median risk-standardized in-hospital mortality rate was 1.

View Article and Find Full Text PDF

: Neutrophil infiltration is an established signature of Non-Alcoholic Fatty Liver Disease (NAFLD) and Steatohepatitis (NASH). The most abundant neutrophilic peptide, alpha-defensin, is considered a new evolving risk factor in the inflammatory milieu, intimately involved in lipid mobilization. Our objective is to assess for potential association between alpha-defensin immunostains and NAFLD severity.

View Article and Find Full Text PDF

The extent of the protection against SARS-CoV-2 conferred by natural infection is unclear. Vitamin D may have a role in the interplay between SARS-CoV-2 infection and the evolving acquired immunity against it. We tested the correlation between baseline 25(OH) D content and both the reinfection rate and the anti-spike protein antibody titer following COVID-19 infection.

View Article and Find Full Text PDF

Objective: Vaccines against COVID-19 induce specific antibodies whose titer is perceived as a reliable correlate of protection. Vitamin D confers complex regulatory effects on the innate and adaptive immunity. In this study, we explored a plausible impact of baseline vitamin D content on achieved immunity following COVID-19 vaccination.

View Article and Find Full Text PDF

Objective: Inflammation is associated with atherogenesis. Although a higher neutrophil count is associated with the plaque burden, the role of neutrophil activation is unclear. Human neutrophil peptides 1-3 (HNP1-3) are a risk factor for atherogenesis in bench models and are elevated in human atheromas.

View Article and Find Full Text PDF

Patients who are severely affected by coronavirus disease 2019 (COVID-19) may develop a delayed onset 'cytokine storm', which includes an increase in interleukin-6 (IL-6). This may be followed by a pro-thrombotic state and increased D-dimers. It was anticipated that tocilizumab (TCZ), an anti-IL-6 receptor monoclonal antibody, would mitigate inflammation and coagulation in patients with COVID-19.

View Article and Find Full Text PDF

The inflammatory response to SARS/CoV-2 (COVID-19) infection may contribute to the risk of thromboembolic complications. α-Defensins, antimicrobial peptides released from activated neutrophils, are anti-fibrinolytic and prothrombotic in vitro and in mouse models. In this prospective study of 176 patients with COVID-19 infection, we found that plasma levels of α-defensins were elevated, tracked with disease progression/mortality or resolution and with plasma levels of interleukin-6 (IL-6) and D-dimers.

View Article and Find Full Text PDF

Background: The treatment of myopericarditis is different than that of acute myocardial infarction (AMI). However, since their clinical presentation is frequently similar it may be difficult to distinguish between these entities despite a disparate underlying pathogenesis. Myopericarditis is primarily an inflammatory disease associated with high C-reactive protein (CRP) and relatively low elevated troponin concentrations, while AMI is characterized by the opposite.

View Article and Find Full Text PDF

Background Shortening the pain-to-balloon (P2B) and door-to-balloon (D2B) intervals in patients with ST-segment-elevation myocardial infarction (STEMI) treated by primary percutaneous coronary intervention (PPCI) is essential in order to limit myocardial damage. We investigated whether direct admission of PPCI-treated patients with STEMI to the catheterization laboratory, bypassing the emergency department, expedites reperfusion and improves prognosis. Methods and Results Consecutive PPCI-treated patients with STEMI included in the ACSIS (Acute Coronary Syndrome in Israel Survey), a prospective nationwide multicenter registry, were divided into patients admitted directly or via the emergency department.

View Article and Find Full Text PDF

Atherosclerosis, the predominant cause of death in well-resourced countries, may develop in the presence of plasma lipid levels within the normal range. Inflammation may contribute to lesion development in these individuals, but the underlying mechanisms are not well understood. Transgenic mice expressing α-def-1 released from activated neutrophils develop larger lipid and macrophage-rich lesions in the proximal aortae notwithstanding hypocholesterolemia caused by accelerated clearance of α-def-1/low-density lipoprotein (LDL) complexes from the plasma.

View Article and Find Full Text PDF

Background: Previous studies, published before the advent of primary reperfusion, described the electrocardiographic features of ST-segment elevation myocardial infarction (STEMI) caused by total diagonal artery occlusion, as demonstrated at pre-discharge coronary angiography. We aimed to assess the electrocardiographic and echocardiographic features in STEMI unequivocally attributed to a diagonal lesion in the era of primary coronary intervention.

Methods: The electrocardiograms and echocardiograms of patients sustaining STEMI caused by diagonal artery involvement were compared with those of patients with STEMI attributed to proximal or mid left anterior descending artery (LAD) lesions.

View Article and Find Full Text PDF